Role of Interleukin-22 in ulcerative colitis

Biomed Pharmacother. 2023 Mar:159:114273. doi: 10.1016/j.biopha.2023.114273. Epub 2023 Jan 23.

Abstract

Ulcerative Colitis (UC) is a chronic disease, in the progression of which an immune overreaction may play an important role. IL-22 is a member of the IL-10 superfamily of cytokines and is pleiotropic in immune regulation and inflammatory responses. IL-22 can produce protective effects, promote wound healing and tissue regeneration, while it can also induce inflammatory reactions when it is chronically overexpressed. Extensive literatures reported that IL-22 played an essential role in the pathogenic development of UC. IL-22 participates in the whole disease process of UC involving signaling pathways, gene expression regulation, and intestinal flora imbalance, making IL-22 a possible candidate for the treatment of UC. In this paper, the latest knowledge to further elucidate the role of IL-22 in UC was summarized and analyzed.

Keywords: IL-22; IL-22BP; STAT3; Ulcerative Colitis.

Publication types

  • Review

MeSH terms

  • Colitis, Ulcerative* / pathology
  • Cytokines / metabolism
  • Humans
  • Inflammation
  • Interleukin-22
  • Interleukins / metabolism

Substances

  • Interleukins
  • Cytokines